Monday, 20 May 2019

India News

  • Biocon clocks revenue worth $121 mn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Bangalore: Indian biopharma giant Biocon reported healthy growth of 22 percent for Q1 FY14. The firm clocked revenues worth $121 million (Rs723 crore), EBITDA of $29.50 million (Rs175 crore...Read more

  • Trivitron JV to lead immunodiagnostics sector in 3 years

    India |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

    Bangalore: Trivitron Healthcare entered in a strategic partnership with Diasorin Group, a global leader in $11 billion immune segment, in order to establish itself in the immunodiagnostic ...Read more

  • Sandoz focuses on developing modern drugs for TB'

    India |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2012

    Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufactures and markets generic drugs as well as pharmaceutical and biotech...Read more

  • What the UK plans to do at Bangalore India BIO?

    India |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2014

    A positive business environment, access to global expertise and the presence of world renowned universities, is helping the UK to nurture some of the most innovative companies. Life science...Read more

  • Accuray announces first two CyberKnife systems in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Accuray, the premier radiation oncology company, announced that Medanta - The Medicity Cancer Institute, and the Roentgen-BLK Super Speciality Hospital both recently acquired an...Read more

  • India's new pharma pricing policy will be a profitability challenge: Glenn Saldanha

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    The Indian pharmaceutical industry has witnessed a healthy growth in the last decade, driven by factors like rising consumption levels in the country and strong demand from export markets. ...Read more

  • Asia's challenge: Meeting US, EU requirements

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Oct, 2012

    One of the biggest challenges in developing and manufacturing antibodies is proving the equivalence or similarity to the reference product. Antibodies are highly complex molecules with seco...Read more

  • Cipla acquires 51 percent stake in Yemen

    India |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Given the recent preference to local manufacturing, this secures the company's presence in a fast growing market. Cipla already has a leading position in Yemen with over 200 pro...Read more

  • Asia has potential in NGS research: Dr Partha Majumdar

    India |  Influencers | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2012

    Dr Partha Majumder is a principal investigator representing India in the International Cancer Genome Consortium, focussing on oral cancer as a part of the ICGC activities, particularly the ...Read more

  • Indian President praises 1Clik diabetes device

    India |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jan, 2013

    Mumbai: The Indian President, Mr Pranab Mukherjee, and the Governor of the Indian state of Tripura, Dr D Y Patil, praised the latest ground breaking diabetes device developed by Rana Arefie...Read more

  • Boehringer heart drug is particularly effective in Asian population

    India |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Boehringer Ingelheim has reported that in Asian populations, Pradaxa (dabigatran etexilate) offers considerable benefits for the management of patients with atrial fibrillation (...Read more

  • Apollo India to setup proton therapy cancer center

    India |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2013

    Chennai: Apollo Hospitals will establish a Proton Therapy Center in India, the first of its kind across South East Asia, Africa and Australia. The launch marks the beginning of the next w...Read more

  • Biocon insulin study gives positive results

    India |  Company results | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2012

    Bangalore: The global phase III study for Biocon's recombinant human insulin (Insugen(R)), in Type 1 diabetes mellitus patients, has demonstrated comparable safety and efficacy with the inn...Read more

  • India to soon decide on FDI policy in pharma

    India |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: Ahead of the raging issue of Foreign Direct Investment (FDI) in the pharmaceutical sector in India, the country's finance minister P chadambaram has said that the government woul...Read more

  • Biocon's earnings surge in Q1 FY16

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2015

    Biocon announced that it has delivered a strong consolidated financial performance for Q1 FY16. Commenting on the quarterly performance and highlights, Chairperson and Managing Director, K...Read more

  • India's H1N1 vaccine demand to grow by 2.1%

    India |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Singapore: Business intelligence provider GlobalData estimates that India is expected to exhibit a great surge in H1N1 vaccine demand over the next 10 years, climbing at an annual growth r...Read more

  • Pain killer from Venus Remedies gets BioSpectrum award

    India |  News | By BioSpectrum Bureau  | 0 Comment | 14 Mar, 2012

    Aceclofenac injection, launched under the brandname of Achnil, by Venues Remedies is a non-steroidal anti-inflammatory drug (NSAID) that is used to relieve acute and chronic pain and infla...Read more

  • US Governor visits Jubilant office in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 08 Oct, 2012

    New Delhi: Ms Christine Gregoire, governor of Washington, the US, visited the headquarters of Jubilant Life Sciences at Noida, India. The integrated pharmaceuticals and life sciences compan...Read more



Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls